RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
USANA Health Sciences Stock

USANA Health Sciences Net Income 2024

USANA Health Sciences Net Income

47.63 M USD

Ticker

USNA

ISIN

US90328M1071

WKN

923145

In 2024, USANA Health Sciences's profit amounted to 47.63 M USD, a -25.33% increase from the 63.79 M USD profit recorded in the previous year.

The USANA Health Sciences Net Income history

YEARNET INCOME (undefined USD)
2026e52.3
2025e48.31
2024e47.63
202363.79
202269.4
2021116.5
2020124.7
2019100.5
2018126.2
201762.5
2016100
201594.7
201476.6
201379
201266.4
201124
201045.7
200933.6
200829.9
200745
200640.4
200538.9
200430.8

USANA Health Sciences Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into USANA Health Sciences, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by USANA Health Sciences from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects USANA Health Sciences’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of USANA Health Sciences. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into USANA Health Sciences’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing USANA Health Sciences’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on USANA Health Sciences’s growth potential.

USANA Health Sciences Revenue, EBIT and net profit per share

DateUSANA Health Sciences RevenueUSANA Health Sciences EBITUSANA Health Sciences Net Income
2026e885.89 M undefined61.51 M undefined52.3 M undefined
2025e861.12 M undefined63.14 M undefined48.31 M undefined
2024e866.73 M undefined73.54 M undefined47.63 M undefined
2023921.01 M undefined93.07 M undefined63.79 M undefined
2022998.6 M undefined107.6 M undefined69.4 M undefined
20211.19 B undefined170.2 M undefined116.5 M undefined
20201.13 B undefined176.5 M undefined124.7 M undefined
20191.06 B undefined146.2 M undefined100.5 M undefined
20181.19 B undefined188.4 M undefined126.2 M undefined
20171.05 B undefined132.5 M undefined62.5 M undefined
20161.01 B undefined138.6 M undefined100 M undefined
2015918.5 M undefined141.7 M undefined94.7 M undefined
2014790.5 M undefined116.1 M undefined76.6 M undefined
2013718.2 M undefined116.7 M undefined79 M undefined
2012648.7 M undefined98.2 M undefined66.4 M undefined
2011581.9 M undefined77.3 M undefined24 M undefined
2010517.6 M undefined68.2 M undefined45.7 M undefined
2009436.9 M undefined50.8 M undefined33.6 M undefined
2008429 M undefined48 M undefined29.9 M undefined
2007423.1 M undefined70.7 M undefined45 M undefined
2006365.2 M undefined62.5 M undefined40.4 M undefined
2005315 M undefined60 M undefined38.9 M undefined
2004259 M undefined44.6 M undefined30.8 M undefined

USANA Health Sciences stock margins

The USANA Health Sciences margin analysis displays the gross margin, EBIT margin, as well as the profit margin of USANA Health Sciences. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for USANA Health Sciences.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the USANA Health Sciences's sales revenue. A higher gross margin percentage indicates that the USANA Health Sciences retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the USANA Health Sciences's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the USANA Health Sciences's total revenue generated. When comparing the revenue margin year over year, investors can gauge the USANA Health Sciences's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the USANA Health Sciences. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the USANA Health Sciences's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

USANA Health Sciences Margin History

USANA Health Sciences Gross marginUSANA Health Sciences Profit marginUSANA Health Sciences EBIT marginUSANA Health Sciences Profit margin
2026e80.82 %6.94 %5.9 %
2025e80.82 %7.33 %5.61 %
2024e80.82 %8.48 %5.5 %
202380.82 %10.11 %6.93 %
202280.58 %10.78 %6.95 %
202181.64 %14.34 %9.82 %
202081.57 %15.56 %10.99 %
201982.33 %13.78 %9.47 %
201883.12 %15.84 %10.61 %
201782.87 %12.65 %5.97 %
201682.09 %13.78 %9.94 %
201582.61 %15.43 %10.31 %
201482.19 %14.69 %9.69 %
201382.25 %16.25 %11 %
201282.15 %15.14 %10.24 %
201182.52 %13.28 %4.12 %
201081.57 %13.18 %8.83 %
200979.45 %11.63 %7.69 %
200879.28 %11.19 %6.97 %
200779.25 %16.71 %10.64 %
200678.12 %17.11 %11.06 %
200578.19 %19.05 %12.35 %
200477.72 %17.22 %11.89 %

USANA Health Sciences Aktienanalyse

What does USANA Health Sciences do?

USANA Health Sciences Inc is an American company that was founded in 1992 by Dr. Myron Wentz. Originally headquartered in Salt Lake City, Utah, the company now operates in over 20 countries worldwide. The main mission of USANA is to help people live healthier lives through high-quality supplements and a healthy lifestyle. USANA is a direct sales company, which means that its products are sold by independent distributors. These distributors earn a commission on their sales and can also have additional income opportunities by building a network of distributors. USANA's business model is based on the idea that people can improve their well-being and enhance their lives by using high-quality supplements and adopting a healthy lifestyle. USANA offers a wide range of products in various categories, including supplements for adults and children, weight management products, personalized vitamins and minerals, skincare products, as well as energy and fitness products. The quality of USANA's products is ensured through strict quality assurance measures and independent certification by NSF International, a third-party company that verifies the safety and efficacy of supplements. USANA also has several divisions, including USANA Health Sciences, Inc., USANA Pacific, Ltd., and BabyCare Ltd. USANA Health Sciences, Inc. is the company's main focus, specializing in the development and distribution of health-related products. USANA Pacific Ltd. is a wholly independent company that focuses on developing and distributing products for customers in Australia, New Zealand, and Asia. BabyCare Ltd. is a company specialized in manufacturing skincare products for babies. USANA has also established a charitable organization, the USANA Foundation, to carry out philanthropic work in various communities around the world. The USANA Foundation addresses basic needs such as health, education, and nutrition and supports organizations dedicated to helping children in need. In summary, USANA Health Sciences Inc is a company that is dedicated to improving people's health and well-being. Its direct sales model and use of high-quality ingredients and supplements certified by an independent third party have helped to build consumer trust in USANA's products. USANA has also expanded its reach through the establishment of various divisions and the creation of a charitable organization, allowing it to have a positive impact on many people worldwide. USANA Health Sciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding USANA Health Sciences's Profit Margins

The profit margins of USANA Health Sciences represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of USANA Health Sciences's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating USANA Health Sciences's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

USANA Health Sciences's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When USANA Health Sciences’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about USANA Health Sciences stock

How much profit has USANA Health Sciences made this year?

USANA Health Sciences has made 47.63 M USD this year.

How has the profit developed compared to last year?

The profit has increased by -25.33% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does USANA Health Sciences publish its earnings?

USANA Health Sciences publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of USANA Health Sciences?

The profits of USANA Health Sciences are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of USANA Health Sciences?

You can learn more about the earnings of USANA Health Sciences by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does USANA Health Sciences pay?

Over the past 12 months, USANA Health Sciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, USANA Health Sciences is expected to pay a dividend of 0 USD.

What is the dividend yield of USANA Health Sciences?

The current dividend yield of USANA Health Sciences is .

When does USANA Health Sciences pay dividends?

USANA Health Sciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of USANA Health Sciences?

USANA Health Sciences paid dividends every year for the past 0 years.

What is the dividend of USANA Health Sciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is USANA Health Sciences located?

USANA Health Sciences is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von USANA Health Sciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of USANA Health Sciences from 12/27/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/27/2024.

When did USANA Health Sciences pay the last dividend?

The last dividend was paid out on 12/27/2024.

What was the dividend of USANA Health Sciences in the year 2023?

In the year 2023, USANA Health Sciences distributed 0 USD as dividends.

In which currency does USANA Health Sciences pay out the dividend?

The dividends of USANA Health Sciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von USANA Health Sciences

Our stock analysis for USANA Health Sciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of USANA Health Sciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.